University of Ioannina
Μελέτη της ανοσοϊστοχημικής έκφρασης των πρωτεϊνών των γονιδίων επιδιόρθωσης και διατήρησης του DNA (MMR) σε παθήσεις μαστού: συσχέτιση και με άλλους προγνωστικούς δείκτες
Abstract
dc:descriptionThe pathology of the breast consists a great chapter in pathology of the women. Both benign and malignant lesions are thought to develop due to genetic and/or epigenetic defects. One of the mechanisms involved is genetic instability and the DNA repair system. The purpose of the present study was to investigate the expression of three of proteins encoded by the DNA mismatch repair genes, namely hMLH1, hMSH2 and hMSH6 and also the expression of BRCA1 gene product that is also involved in the DNA repair system in benign breast lesions, in situ carcinomas and invasive carcinomas of the breast, familial and sporadic. The expression of these proteins was monitored immunohistochemically in 190 benign breast lesions (adenomas, fibroadenomas, radial scars, papillomas, fibrocystic disease with or without epithelial hyperplasia etc.), 60 in situ carcinomas, 30 familial invasive carcinomas and 124 invasive sporadic carcinomas of various types and grades. We did not detect any loss of hMLH1, hMSH2 and hMSH6 expression in the material that included the benign lesions and the in situ carcinomas. Concerning invasive carcinomas, we detected loss of the mismatch repair proteins in 43,3% (MLH1), 16,7% (MSH2) and 46,7% (MSH6) in familial cases and 40,3% (MLH1), 26% (MSH2) 51,6% (MSH6) in sporadic cases examined. The reduced or absent expression of these proteins was correlated with higher histological grade, negative estrogen receptor status, overexpression of the c-erbB-2 oncogene and higher lymphatic density, peritumoral and intratumoral. Especially, loss of MSH2 protein was strongly statistically correlated with increased frequency of lymph node metastases and loss of BRCA1 protein. BRCA1 reduction in breast carcinomas usually characterizes highly malignant tumors. In addition, loss or reduction of hMLH1 and BRCA1 protein was associated with worse overall survival in the group of sporadic carcinomas, but it had no effect on the survival curves in the familial cases examined. The published data concerning the mismatch repair protein expression and its relationship with breast pathology are few and the reports are variable and controversial. Recent studies have shown that there is a high correlation between MMR-deficiency and loss of expression of the related proteins. Additionally, imuunohistochemistry is a rapid and simple technique and it can be used in everyday practice in order to detect the patients that carry these genetic/epigenetic disorder. Our results suggest that the DNA mismatch repair system is involved in breast carcinogenesis, in both familial and sporadic cases, but it is not an early event. Defects in the DNA mismatch repair system seem to occur during progression from in situ to invasive carcinoma. The MMR-deficiency affects prognosis and therefore the management and therapeutic procedures of the patients.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Arkoumani, Evdokia
- Αρκουμάνη, Ευδοκία
Subjects
dc:subject × 9Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21942